erythema/inflammation

CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority under 35 U.S.C. .sctn. 119 to Korean Patent Application No. 10-2017-0050831, filed on Apr. 20, 2017 and Korean Patent Application No. 10-2018-0045029, filed on Apr. 18, 2018, in the Korean Intellectual Property Office, the

FIELD OF THE INVENTION This invention relates generally to the field of devices for detecting the health status of the pulp tissue within a tooth, and more particularly to a device and method for using a combination of light and acoustics to measure the degree of erythema in a tooth. BACKGROUND OF

FIELD OF THE INVENTION This invention relates to a topical treatment and composition which may be applied to mitigate inflammatory symptoms such as burning, redness, itching, swelling and pain which accompany skin disorders, either of an acute or chronic nature. BACKGROUND OF THE INVENTION Many skin

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a process of treating inflammation in a joint, such as but not limited to a knee joint, a hip joint or an ankle joint, which has been damaged or which has otherwise become defective, and thereby, alleviating pain,

Damage of tissues can be induced in many ways. Inducing factors can be correlated with mechanical effects, immunological effects or chemical effects. Microorganisms such as virus, bacteria and fungus can induce tissue damage and exposure to heat, fire, radiation, cold and blows most often results in

FIELD OF THE INVENTION This invention pertains to therapeutic methods of preventing, and the treatment and repair of damaged cells and tissues from injuries and the resulting disease states in mammals caused by the inflammatory production of pain, erythema, itching, crusting, swelling, an

REFERENCE TO A SEQUENCE LISTING SUBMITTED IN A COMPUTER READABLE FORMAT The sequence listing written in the file 483620_SEQLST.txt is 18,070 bytes, and was created on Aug. 23, 2016 and is hereby incorporated by reference. BACKGROUND OF THE INVENTION Many drugs are required to be taken up by cells or

REFERENCE TO A SEQUENCE LISTING SUBMITTED IN A COMPUTER READABLE FORMAT The sequence listing written in the file 413219_SEQLST.TXT is 18,027 bytes, and was created on Jun. 11, 2012 and is hereby incorporated by reference. BACKGROUND OF THE INVENTION Many drugs are required to be taken up by cells or

BACKGROUND OF THE INVENTION Many drugs are required to be taken up by cells or pass through cells and/or be taken up by cellular organelles to reach their intended therapeutic target. Many larger molecules and some small ones by themselves have limited capacity to pass through cellular membranes.

TECHNICAL FIELD The present disclosure consists of therapeutically-active compositions that combine strontium with at least one additional molecules that increase the overall therapeutic potency of the combination beyond the potency of any of the separate constituents. Specifically, the combinations

TECHNICAL FIELD The present disclosure consists of therapeutically-active compositions that combine strontium with at least one additional molecules that increase the overall therapeutic potency of the combination beyond the potency of any of the separate constituents. Specifically, the combinations

TECHNICAL FIELD The present disclosure consists of therapeutically-active compositions that combine strontium with at least one additional molecules that increase the overall therapeutic potency of the combination beyond the potency of any of the separate constituents. Specifically, the combinations

BACKGROUND OF THE INVENTION The present invention is direction to the treatment of acne and other inflammatory conditions. More specifically, in some embodiments this invention relates to methods for treating acne which methods comprise the topical application of muscarinic agents such as

TECHNICAL FIELD This invention relates generally to the field of pharmacotherapeutics and the use of photodynamic therapy ("PDT") to reduce or prevent inflammation due to injured tissue, whether by intestinal injury, such as surgery, or by accidental injury, such as skin lacerations, injuries to

TECHNICAL FIELD This invention relates generally to the field of pharmacotherapeutics and the use of photodynamic therapy ("PDT") to reduce or prevent inflammation due to injured tissue, whether by intestinal injury, such as surgery, or by accidental injury, such as skin lacerations, injuries to